ATA285187A - Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel - Google Patents
Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittelInfo
- Publication number
- ATA285187A ATA285187A AT2851/87A AT285187A ATA285187A AT A285187 A ATA285187 A AT A285187A AT 2851/87 A AT2851/87 A AT 2851/87A AT 285187 A AT285187 A AT 285187A AT A285187 A ATA285187 A AT A285187A
- Authority
- AT
- Austria
- Prior art keywords
- production
- amino acids
- products containing
- alpha amino
- medicinal products
- Prior art date
Links
- 235000008206 alpha-amino acids Nutrition 0.000 title 1
- 150000001371 alpha-amino acids Chemical class 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868625941A GB8625941D0 (en) | 1986-10-30 | 1986-10-30 | Substituted alpha-amino acids |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA285187A true ATA285187A (de) | 1991-03-15 |
AT393384B AT393384B (de) | 1991-10-10 |
Family
ID=10606531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT2851/87A AT393384B (de) | 1986-10-30 | 1987-10-29 | Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel |
Country Status (27)
Country | Link |
---|---|
US (1) | US5162311A (de) |
JP (2) | JPH0641475B2 (de) |
KR (1) | KR950004960B1 (de) |
AT (1) | AT393384B (de) |
AU (1) | AU614726B2 (de) |
BE (1) | BE1002421A4 (de) |
CA (1) | CA1310331C (de) |
CH (1) | CH677794A5 (de) |
CY (1) | CY1703A (de) |
DE (1) | DE3736016C2 (de) |
DK (1) | DK565987A (de) |
ES (1) | ES2012521A6 (de) |
FI (1) | FI87222C (de) |
FR (1) | FR2606018B1 (de) |
GB (2) | GB8625941D0 (de) |
GR (1) | GR871659B (de) |
HK (1) | HK110393A (de) |
HU (1) | HU200465B (de) |
IE (1) | IE59310B1 (de) |
IL (1) | IL84302A (de) |
IT (1) | IT1212033B (de) |
LU (1) | LU87031A1 (de) |
NL (1) | NL8702485A (de) |
NZ (1) | NZ222333A (de) |
PT (1) | PT86018B (de) |
SE (1) | SE466311B (de) |
ZA (1) | ZA878176B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5395827A (en) * | 1986-04-09 | 1995-03-07 | Guilford Pharmaceuticals Inc. | ω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptors |
US4918064A (en) * | 1987-10-21 | 1990-04-17 | G. D. Searle & Co. | Phenyl glycines for use in reducing neurotoxic injury |
US5175153A (en) * | 1987-11-30 | 1992-12-29 | Warner-Lambert Company | Substituted alpha-amino acids having pharmaceutical activity |
FR2634763B1 (fr) * | 1988-08-01 | 1991-07-12 | Inst Nat Sante Rech Med | Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments |
US4997821A (en) * | 1988-10-21 | 1991-03-05 | Cordi Alexis A | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
US5177240A (en) * | 1988-10-21 | 1993-01-05 | G. D. Searle & Co. | O-phosphono(alkyl)-n-sulfonyl-phenyl-alanine derivatives useful as intermediates for preparation of phosphono-hydroisoquinolines |
US5100654A (en) * | 1989-04-07 | 1992-03-31 | Yale University | Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair |
DE3940410A1 (de) * | 1989-12-04 | 1991-06-06 | Schering Ag | Neue verwendung von nmda-rezeptor-antagonisten |
US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
US5475129A (en) * | 1991-09-30 | 1995-12-12 | The United States Of America As Represented By The Department Of Health And Human Services | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis |
US5264607A (en) * | 1991-09-30 | 1993-11-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates |
US5200546A (en) * | 1991-09-30 | 1993-04-06 | The United States Of America As Represented By The Department Of Health And Human Services | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis |
GB9325360D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
US5489717A (en) * | 1994-07-08 | 1996-02-06 | Warner-Lambert Company | Glutamate (NMDA) receptor antagonists |
GB9423019D0 (en) * | 1994-11-15 | 1995-01-04 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5922697A (en) * | 1996-10-02 | 1999-07-13 | Warner-Lambert Company | Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins |
US6133281A (en) * | 1996-10-24 | 2000-10-17 | Harbor-Ucla Research And Education Institute | NMDA receptor blockers in the therapy of urogenital disease |
EP1009407B1 (de) * | 1997-09-04 | 2004-04-28 | Novoneuron, Inc. | Noribogain zur behandlung von schmerzen und drogenabhängigkeit |
MY153569A (en) * | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
SE9804064D0 (sv) * | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
MY140707A (en) * | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
DE10328260A1 (de) * | 2003-06-23 | 2005-01-27 | Schmidt, K.-G., Dr. med. | Flupirtine-Präparat |
EP1754483A1 (de) * | 2005-08-18 | 2007-02-21 | Merck Sante | Verwendung von Thienopyridonederivativen als AMPK Aktivatoren und pharmazeutische Zusammensetzungen, die diese enthalten |
JP2013534914A (ja) | 2010-06-09 | 2013-09-09 | クイーン マリー アンド ウエストフィールド カレッジ、ユニバーシティ オブ ロンドン | アネキシン1抗体 |
GB201121564D0 (en) * | 2011-12-14 | 2012-01-25 | Queen Mary & Westfield College | Use of antibody |
GB201702091D0 (en) | 2017-02-08 | 2017-03-22 | Medannex Ltd | Specific binding molecules |
EP3427729A1 (de) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE550634A (de) * | 1955-08-30 | |||
BE626546A (de) * | 1961-12-30 | |||
DE2459491A1 (de) * | 1974-12-17 | 1976-06-24 | Bayer Ag | Gegenueber isocyanaten reaktive phosphorhaltige flammschutzmittel |
US4657899A (en) * | 1986-04-09 | 1987-04-14 | Nova Pharmaceutical Corporation | Antagonists of specific excitatory amino acid neurotransmitter receptors |
US4761405A (en) * | 1987-03-04 | 1988-08-02 | Nova Pharmaceutical Corporation | Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency |
US4918064A (en) * | 1987-10-21 | 1990-04-17 | G. D. Searle & Co. | Phenyl glycines for use in reducing neurotoxic injury |
-
1986
- 1986-10-30 GB GB868625941A patent/GB8625941D0/en active Pending
-
1987
- 1987-10-15 GB GB8724186A patent/GB2198134B/en not_active Expired - Lifetime
- 1987-10-16 NL NL8702485A patent/NL8702485A/nl active Search and Examination
- 1987-10-16 HU HU874665A patent/HU200465B/hu not_active IP Right Cessation
- 1987-10-23 CH CH4169/87A patent/CH677794A5/de not_active IP Right Cessation
- 1987-10-23 DE DE3736016A patent/DE3736016C2/de not_active Expired - Fee Related
- 1987-10-26 FR FR878714891A patent/FR2606018B1/fr not_active Expired - Lifetime
- 1987-10-26 BE BE8701221A patent/BE1002421A4/fr not_active IP Right Cessation
- 1987-10-28 NZ NZ222333A patent/NZ222333A/xx unknown
- 1987-10-28 AU AU80404/87A patent/AU614726B2/en not_active Ceased
- 1987-10-28 SE SE8704204A patent/SE466311B/sv not_active IP Right Cessation
- 1987-10-28 DK DK565987A patent/DK565987A/da not_active Application Discontinuation
- 1987-10-28 PT PT86018A patent/PT86018B/pt not_active IP Right Cessation
- 1987-10-28 IT IT8748544A patent/IT1212033B/it active
- 1987-10-28 LU LU87031A patent/LU87031A1/fr unknown
- 1987-10-28 IL IL84302A patent/IL84302A/xx not_active IP Right Cessation
- 1987-10-29 CA CA000550571A patent/CA1310331C/en not_active Expired - Lifetime
- 1987-10-29 GR GR871659A patent/GR871659B/el unknown
- 1987-10-29 JP JP62274594A patent/JPH0641475B2/ja not_active Expired - Lifetime
- 1987-10-29 FI FI874761A patent/FI87222C/fi not_active IP Right Cessation
- 1987-10-29 IE IE290887A patent/IE59310B1/en not_active IP Right Cessation
- 1987-10-29 AT AT2851/87A patent/AT393384B/de not_active IP Right Cessation
- 1987-10-29 KR KR1019870011983A patent/KR950004960B1/ko not_active IP Right Cessation
- 1987-10-30 ZA ZA878176A patent/ZA878176B/xx unknown
- 1987-10-30 ES ES8703112A patent/ES2012521A6/es not_active Expired - Lifetime
-
1990
- 1990-08-02 JP JP2206678A patent/JPH03101685A/ja active Pending
-
1991
- 1991-08-19 US US07/747,177 patent/US5162311A/en not_active Expired - Fee Related
-
1993
- 1993-10-21 HK HK1103/93A patent/HK110393A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY170394A patent/CY1703A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA285187A (de) | Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel | |
DE3751845D1 (de) | Stabilisiertes Arzneimittel und dessen Herstellung | |
DE3780329D1 (de) | Chinoloncarbonsaeure-derivate und ihre herstellung. | |
ATE124951T1 (de) | Fluorcytidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten. | |
DE3782751D1 (de) | Hydroxylaminderivate, deren herstellung und verwendung fuer heilmittel. | |
DE3780223D1 (de) | Arzneimittel mit gesteuerter freisetzung. | |
DE3580616D1 (de) | Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
AT388913B (de) | Neue n-(2'-aminophenyl)-benzamid-derivate und arzneimittel, die diese enthalten | |
DE3785684D1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. | |
DE3771146D1 (de) | Pyrimidinderivate, ihre herstellung und medikamente, die diese derivate enthalten. | |
DE3670639D1 (de) | Neue biphosphonische abkoemmlinge, deren herstellung und arzneimittelzubereitung. | |
DE3685604D1 (de) | 1,7-naphthyridinderivate und diese enthaltende arzneimittel. | |
ATE40826T1 (de) | 4'-demethyl-4-epipodophyllotoxinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE3876913D1 (de) | Herstellung von kohlenstoffhaltigen pulvern und ihre granulierung. | |
DE68901859D1 (de) | 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung. | |
DE3782112D1 (de) | Pyrimidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten. | |
DK103987A (da) | Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler | |
ATA36788A (de) | Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel | |
DE59002899D1 (de) | Aromatische carbonsaeureamide, ihre herstellung und verwendung fuer heilmittel. | |
DE3578597D1 (de) | 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE32882T1 (de) | Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten. | |
DE3786927D1 (de) | Antithrombotische arzneimittel und deren herstellung. | |
DE3676360D1 (de) | Nitroderivate von vinblastintyp-bis-indolen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
IT1211681B (it) | Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti | |
DE3761379D1 (de) | 1,3-propandiaminderivate, ihre herstellung und sie enthaltende arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |